JAK2 and Alzheimer disease: We found that inhibition of the JAK2-STAT3 pathway normalizes several features of astrocyte reactivity and improves three key pathological hallmarks in AD mouse models, showing that reactive astrocytes have deleterious effects in AD (Fig. 9).